LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.14 | 84.90 | 1329 | 3682 | 0.3609 | 0.6583 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 40.14 | 84.90 | 1363 | 3682 | 0.3702 | 0.6660 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.84 | 84.90 | 1035 | 4003 | 0.2586 | 0.5680 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.84 | 84.90 | 1050 | 4003 | 0.2623 | 0.5721 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.84 | 84.90 | 1314 | 4003 | 0.3282 | 0.6368 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 41.84 | 84.90 | 1347 | 4003 | 0.3365 | 0.6442 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.55 | 84.90 | 1052 | 4287 | 0.2453 | 0.5602 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.55 | 84.90 | 1067 | 4287 | 0.2488 | 0.5641 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.55 | 84.90 | 1352 | 4287 | 0.3153 | 0.6310 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 43.55 | 84.90 | 1383 | 4287 | 0.3225 | 0.6375 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.25 | 84.90 | 1051 | 4539 | 0.2315 | 0.5500 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.25 | 84.90 | 1066 | 4539 | 0.2348 | 0.5539 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.25 | 84.90 | 1420 | 4539 | 0.3128 | 0.6335 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 45.25 | 84.90 | 1456 | 4539 | 0.3207 | 0.6406 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 46.95 | 84.90 | 1114 | 4952 | 0.2249 | 0.5509 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 46.95 | 84.90 | 1129 | 4952 | 0.2280 | 0.5544 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 46.95 | 84.90 | 1433 | 4952 | 0.2894 | 0.6189 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 46.95 | 84.90 | 1465 | 4952 | 0.2958 | 0.6250 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 48.65 | 84.90 | 1142 | 5328 | 0.2143 | 0.5453 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 48.65 | 84.90 | 1159 | 5328 | 0.2175 | 0.5491 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 48.65 | 84.90 | 1506 | 5328 | 0.2826 | 0.6186 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 48.65 | 84.90 | 1529 | 5328 | 0.2869 | 0.6227 | MN20160318_Q02 | I05 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 50.36 | 84.90 | 1206 | 5651 | 0.2134 | 0.5498 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 50.36 | 84.90 | 1215 | 5651 | 0.2150 | 0.5517 | MN20160318_Q02 | F03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 50.36 | 84.90 | 1526 | 5651 | 0.2700 | 0.6112 | MN20160318_Q02 | I05 |